WHEATON Announces Acquisition of CELLineTM
July 9, 2012
WHEATON has acquired the CELLine dual membrane, cell culture flasks from Wilson Wolf Manufacturing Corporation. WHEATON has also entered into a long term strategic partnership with Wilson Wolf Manufacturing Corporation for further product development in high density cell culture devices for the production of concentrated, cell secreted products. CELLine Flasks are known by their loyal [...]
July 9, 2012
Järfälla, Sweden, – Silex Microsystems, the world’s largest pure-play MEMS foundry, today announced that VINNOVA, the Swedish Governmental Agency for Innovation Systems, has awarded a nearly 10M SEK grant towards a 30M SEK program to a consortium of 10 Swedish companies to advance high-tech manufacturing of MEMS-based gas sensing systems in Sweden – the global [...]
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
July 9, 2012
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it received FDA clearance to market the BD MAX™ MRSA molecular test in the United States. The assay is performed on the fully-automated BD MAX™ System and is designed to rapidly and accurately identify patients colonized with methicillin-resistant [...]
Chiral Technologies Welcomes Dr. Jauh-Tzuoh Lee as Technology Manager
July 9, 2012
WEST CHESTER, Pa. — Chiral Technologies, Inc., (CTI) announced that Jauh-Tzuoh (J.T.) Lee, Ph.D., has joined the company as Technology Manager. In this position, Dr. Lee will be responsible for planning and directing CTI’s technology activities and providing leadership in the development of new products. Reporting to Joseph Barendt, Ph.D., Chief Operating Officer, Dr. Lee [...]
July 9, 2012
LEXINGTON, Mass -- BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the in vitro and in vivo kinase expression in the MAP kinase pathway at the 22nd Biennial European Association for Cancer Research (EACR) Congress, held in Barcelona, Spain, July [...]
Horizon Discovery and Bayer Collaborate to Develop Cell Line Models to Support Oncology Programs
July 9, 2012
Cambridge, UK,- Horizon Discovery Ltd (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced it has signed a collaboration agreement with Bayer Pharma AG (Bayer) to develop preclinical cell line models that will support Bayer’s oncology research and development programs, using Horizon’s precision genome editing technology, GENESIS™. The [...]
Knome Appoints Heidi L. Rehm, PhD, to Scientific Advisory Board
July 9, 2012
CAMBRIDGE, Mass.-- Knome Inc., the human genome interpretation company, announced today that a leading clinical geneticist, Heidi Rehm, PhD, has joined the company’s scientific advisory board. Dr. Rehm is highly respected and influential figure in clinical genomics,” said Martin Tolar, MD, PhD, Chief Executive Officer of Knome. “We are very pleased to welcome Dr. Rehm [...]
As per July 1st the Verder Group has acquired the UK group of companies: Carbolite
July 6, 2012
Based in the beautiful English Peak District, Carbolite is the leading manufacturing of laboratory and industrial furnaces. The company has 160 employees and has own distribution companies in Germany, France and the USA which have provided for significant growth during the past years. Carbolite will be an important part of the Verder Groups laboratory division [...]
Mediatech Expands Corning cellgro® Serum-free Offerings with hybriGRO SF™
July 6, 2012
MANASSAS, Va., -- Mediatech Inc., a subsidiary of Corning Incorporated (NYSE:GLW), announced today the introduction of hybriGRO SF™, which enhances the performance of monoclonal antibody-producing hybridoma cells. Monoclonal antibodies (mAbs) derived from hybridoma cells (cells formed from the fusion of antibody-producing B-cells with myeloma cells) are used extensively in the prevention, diagnosis, and treatment of [...]
Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
July 6, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today confirmed that the United States District Court for the Northern District of California has denied a motion by Sequenom for a preliminary injunction against Ariosa Diagnostics. "While obviously a disappointing preliminary outcome in our efforts to enforce an [...]
